logo

Aradigm Corp (ARDM)



Trade ARDM now with
  Date
  Headline
10/30/2019 8:42:03 PM Aradigm Announces Withdrawal Of European Marketing Authorization Application For Linhaliq
1/30/2019 8:06:04 AM Aradigm Announces Submission Of Responses To EMA Day 120 Questions And Meeting With FDA
12/20/2018 8:17:21 AM Aradigm Announces Results Of Third Party Verification For Apulmiq
11/15/2018 8:14:06 AM Aradigm Q3 Net Loss $3.6 Mln Or $0.24/shr Vs. Net Loss Of $3.9 Mln Or $0.26/shr Prior Year
8/14/2018 8:08:46 AM Aradigm Q2 Net Loss $3.8 Mln Or $0.25/shr Vs. Net Income $1.0 mln Or $0.07/shr Last Year
4/5/2018 8:23:46 AM Aradigm Announces EMA Has Completed Its Validation Of MAA Submission For Linhaliq
3/23/2018 8:04:02 AM Aradigm Q4 Net Loss $4.2 Mln Or $0.28/Shr Vs Loss Of $7.9 Mln Or $0.54/Shr Last Year
3/9/2018 8:03:53 AM Aradigm Submits MAA To EMA For EU Marketing Approval Of Linhaliq In Non-Cystic Fibrosis Bronchiectasis
1/29/2018 7:03:00 AM Aradigm Receives Complete Response Letter From FDA For Linhaliq NDA
1/11/2018 6:59:44 AM Aradigm Trading Halted; Pending News
  
 
>